(3β,5α,8α,22E)-5,8-[N,N-(4-Phenylurazole)]-ergosta-6,22-diene-3,24,25-triol-d3 3-Acetate
| Product Name |
(3β,5α,8α,22E)-5,8-[N,N-(4-Phenylurazole)]-ergosta-6,22-diene-3,24,25-triol-d3 3-Acetate
|
| Product Code |
DA-E105-18
|
| Chemical name |
(3β,5α,8α,22E)-5,8-[N,N-(4-Phenylurazole)]-ergosta-6,22-diene-3,24,25-triol-d3 3-Acetate
|
| Synonyms |
(3β,5α,8α,22E)-3-Acetyloxy-24,25-dihydroxy-5,8-(3,5-dioxo-4-phenyl)-1,2,4-triazolidinol-ergosta-6,22-diene-d3
|
| Impurity |
NA
|
| CAS Number |
NA
|
| Alternate CAS # |
NA
|
| Molecular form |
C38H48D3N3O6
|
| Appearance |
White Solid
|
| Melting Point |
NA
|
| Mol. Weight |
648.85
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
stable isotopes,metabolites,impurities,pharmaceutical standards,intermediates,fine chemicals
|
| Boiling Point |
NA
|
| Applications |
(3β,5α,8α,22E)-5,8-[N,N-(4-Phenylurazole)]-ergosta-6,22-diene-3,24,25-triol-d3 3-Acetate is a labelled intermediate in the preparation of 24,25-Dihydroxy Vitamin D2 a hydroxylated metabolite of Vitamin D2.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
